1. A phase I pharmacokinetic and pharmacodynamic study of the oral mitogen-activated protein kinase kinase (MEK) inhibitor, WX-554, in patients with advanced solid tumours. (November 2016) Authors: Jamieson, David; Griffin, Melanie J.; Sludden, Julieann; Drew, Yvette; Cresti, Nicola; Swales, Karen; Merriman, Mark; Allen, Rodger; Bevan, Paul; Buerkle, Markus; Mala, Carola; Coyle, Vicky; Rodgers, Lisa; Dean, Emma; Greystoke, Alastair; Banerji, Udai; Wilson, Richard H.; Evans, T.R. Jeffery; An... Journal: European journal of cancer Issue: Volume 68(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A population pharmacokinetic model of AT9283 in adults and children to predict the maximum tolerated dose in children with leukaemia. (5th March 2017) Authors: Duong, Janna K.; Griffin, Melanie J.; Hargrave, Darren; Vormoor, Josef; Edwards, David; Boddy, Alan V. Journal: British journal of clinical pharmacology Issue: Volume 83:Number 8(2017) Page Start: 1713 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Strategy to Refine the Phenotyping Approach and Its Implementation to Predict Drug Clearance: A Physiologically Based Pharmacokinetic Simulation Study. (24th October 2018) Authors: Adiwidjaja, Jeffry; Boddy, Alan V.; McLachlan, Andrew J. Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 7:Number 12(2018) Page Start: 798 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions. (2nd September 2017) Authors: Adiwidjaja, Jeffry; McLachlan, Andrew J.; Boddy, Alan V. Journal: Expert opinion on drug metabolism and toxicology Issue: Volume 13:Number 9(2017:Sep.) Page Start: 953 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma. (March 2016) Authors: Veal, Gareth J.; Cole, Michael; Chinnaswamy, Girish; Sludden, Julieann; Jamieson, David; Errington, Julie; Malik, Ghada; Hill, Christopher R.; Chamberlain, Thomas; Boddy, Alan V. Journal: European journal of cancer Issue: Volume 55(2016) Page Start: 56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Development of a physiologically based pharmacokinetic model of actinomycin D in children with cancer. (25th February 2016) Authors: Walsh, Christopher; Bonner, Jennifer J.; Johnson, Trevor N.; Neuhoff, Sibylle; Ghazaly, Essam A.; Gribben, John G.; Boddy, Alan V.; Veal, Gareth J. Journal: British journal of clinical pharmacology Issue: Volume 81:Number 5(2016:May) Page Start: 989 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Genetic variants in the HER2 gene: Influence on HER2 overexpression and loss of heterozygosity in breast cancer. (March 2016) Authors: Cresti, Nicola; Lee, Joanne; Rourke, Emma; Televantou, Despina; Jamieson, David; Verrill, Mark; Boddy, Alan V. Journal: European journal of cancer Issue: Volume 55(2016) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. High‐resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers. Issue 1 (19th August 2015) Authors: Dent, Barry M.; Ogle, Laura F.; O'Donnell, Rachel L.; Hayes, Nicholas; Malik, Ujjal; Curtin, Nicola J.; Boddy, Alan V.; Plummer, E. Ruth; Edmondson, Richard J.; Reeves, Helen L.; May, Felicity E.B.; Jamieson, David Journal: International journal of cancer Issue: Volume 138:Issue 1(2016:Jan. 01) Page Start: 206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Investigating the potential impact of dose banding for systemic anti-cancer therapy in the paediatric setting based on pharmacokinetic evidence. (March 2018) Authors: White-Koning, Melanie; Osborne, Caroline; Paci, Angelo; Boddy, Alan V.; Chatelut, Etienne; Veal, Gareth J. Journal: European journal of cancer Issue: Volume 91(2018) Page Start: 56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Is there scope for better individualisation of anthracycline cancer chemotherapy?. Issue 2 (30th November 2020) Authors: Sallustio, Benedetta C.; Boddy, Alan V. Journal: British journal of clinical pharmacology Issue: Volume 87:Issue 2(2021) Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗